g.pemberton_uk
TL3 Regional · UK · York, UK
Keeps the UK access pages current — MHRA positions, NHS pathways, and what a private prescription actually involves.
Joined 18 September 2024 · last posted 5d · groups: wiki-editors, regional-uk
135 posts, newest first. Showing up to 150.
-
Seven-day rolling means and why weekly readings mislead Replied, post #86 · Outcomes › Progress reports · 22 Jul 2026 · 4 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #63 · Compounds › Repair & healing peptides · 20 Jul 2026 · 10 likes Research use only, not approved for human use, and in this family that statement carries more weight than usual because the published human safety data is effectively…
-
Packaging that arrived damaged: documenting it properly Replied, post #41 · Sourcing › Logistics · 12 Jul 2026 · 3 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #31 · Compounds › Retatrutide · 12 Jul 2026 · 11 likes Fair, and the limits you put on it are the part I will remember.
-
Journal club: what we got wrong in an earlier session Replied, post #73 · Evidence › Journal club · 11 Jul 2026 · 0 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.…
-
Alcohol: what is documented and what is folklore Replied, post #99 · Practice › Interactions · 8 Jul 2026 · 6 likes Post #97 and I disagree about the size of the effect, not about the direction. What would change my mind on alcohol is a second dataset collected by someone with no…
-
Rewriting my first post: a before-and-after, with commentary — what changed since Replied, post #12 · Start Here › How to Ask · 1 Jul 2026 · 5 likes Thank you for taking the time. That was more work than a reply usually is.
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #55 · Evidence › Journal club · 1 Jul 2026 · 31 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. Caveat:…
-
Revisiting: The best-written scientific paper you have read Replied, post #56 · Lounge › Off topic · 27 Jun 2026 · 15 likes Filing a mild objection to the consensus on best-written scientific paper. Mild because I might be wrong; an objection because nobody has addressed the case that does…
-
Constipation management, with a dietitian's contribution Replied, post #84 · Practice › Side effects · 26 Jun 2026 · 0 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
What published stability data actually covers, and what it does not Replied, post #6 · Practice › Storage & stability · 14 Jun 2026 · 2 likes Post #4 put the caveat in the right place and I want to underline it. Posting my published stability data actually covers numbers with the method attached so they can…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #104 · Practice › Reconstitution · 12 Jun 2026 · 0 likes This follows post #102 rather than contradicting it. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into…
-
Revisiting: The best-written scientific paper you have read Replied, post #23 · Lounge › Off topic · 9 Jun 2026 · 5 likes Since best-written scientific paper keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more…
-
Pages past their review date, listed — does this still hold? Started this topic · Meta › Wiki maintenance · 1 Jun 2026 · 12 likes Asking directly, because I could not find a straight answer: Pages past their review date, listed — does this still hold? I have spent a fortnight trying to pin Pages…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #43 · Practice › Storage & stability · 1 Jun 2026 · 15 likes I had written a reply contradicting post #39 and deleted it. Here is what survived. The question underneath Mean kinetic temperature is usually "how would I tell?"…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #16 · Compounds › Secretagogues & GH axis · 29 May 2026 · 0 likes Narrowing post #15, because the general version has more than one answer. Secretagogues and glucose tolerance: there is a mechanistic concern that sustained growth…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #60 · Practice › Reconstitution · 27 May 2026 · 3 likes On post #56 — agreed on the reasoning, with one qualification. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial"…
-
Transporting a vial for a weekend away — a second dataset Replied, post #64 · Practice › Storage & stability · 26 May 2026 · 7 likes Post #62 is right about the mechanism and I think understates the practical bit. Transporting a vial is one of those subjects where the general answer and the answer…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #81 · Sourcing › Logistics · 26 May 2026 · 16 likes Post #79 put the caveat in the right place and I want to underline it. I would be cautious about generalising from the Regional warehouse stock versus direct example…
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #22 · Analytics › Home & field testing · 18 May 2026 · 0 likes Post #19 is right about the mechanism and I think understates the practical bit. Documenting home checks with dates and lots makes them accumulate into something.…
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #9 · Practice › Side effects · 10 May 2026 · 11 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #55 · Practice › Administration · 7 May 2026 · 23 likes Needle length matters less than angle for subcutaneous delivery in most people. A short needle at ninety degrees and a longer one at forty-five put the material in…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #115 · Practice › Reconstitution · 28 Apr 2026 · 3 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. This is the…
-
Restarting after a long gap: what the labelling implies — the long version Replied, post #12 · Practice › Dosing & titration · 22 Apr 2026 · 23 likes Post #8 describes the usual case. This is about the unusual one. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #24 · Practice › Reconstitution · 19 Apr 2026 · 4 likes Taking post #21 at face value and following it one step further. Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #15 · Practice › Reconstitution · 18 Apr 2026 · 0 likes Post #14 is right about the mechanism and I think understates the practical bit. Choose the concentration so that a typical dose lands on a graduation you can actually…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #102 · Practice › Reconstitution · 17 Apr 2026 · 11 likes Where I part company with post #100, and it is a narrow parting. Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing.…
-
List price versus negotiated price versus what you pay Replied, post #112 · Access › Pricing · 17 Apr 2026 · 32 likes On post #108 — agreed on the reasoning, with one qualification. The cost of an independent submission is worth stating in these threads, because it is the main reason…
-
List price versus negotiated price versus what you pay Replied, post #96 · Access › Pricing · 16 Apr 2026 · 0 likes That is clearer than the version I had in my head. Thank you.
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #62 · Start Here › Welcome · 5 Apr 2026 · 4 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Second pass at: Temperature logging at home: what is worth the effort Replied, post #5 · Practice › Storage & stability · 5 Apr 2026 · 10 likes Narrowing post #3, because the general version has more than one answer. A beyond-use date on a home preparation is an inference rather than a measurement. It can be a…
-
A 40-week log with the measurement method stated — does this still hold? Replied, post #4 · Outcomes › Progress reports · 24 Mar 2026 · 10 likes A plateau over two weeks is usually measurement. A plateau over two months is usually energy balance. The timescale is what distinguishes them.
-
Grapefruit: why this class is not the class that cares Replied, post #72 · Practice › Interactions · 23 Mar 2026 · 0 likes Offering a way to settle grapefruit rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the…
-
Restarting after a long gap: what the labelling implies — the long version Replied, post #8 · Practice › Dosing & titration · 22 Mar 2026 · 20 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
-
Foaming during reconstitution and whether it matters — the long version Replied, post #71 · Practice › Reconstitution · 21 Mar 2026 · 29 likes The number people quote for Foaming during reconstitution is a central estimate presented without its interval, and the interval is wide enough that the estimate is…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #38 · Lounge › Introductions · 11 Mar 2026 · 0 likes Good to have another set of eyes on the wiki posts. Community wiki editing is open at trust level three and the queue of small corrections is permanently longer than…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #20 · Compounds › Repair & healing peptides · 10 Mar 2026 · 8 likes The lyophilised cake is worth looking at before adding diluent. A collapsed or shrunken cake is not a purity finding but it does say something about how the vial was…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #29 · Compounds › Cagrilintide & amylin analogues · 26 Feb 2026 · 29 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #67 · Start Here › How to Ask · 25 Feb 2026 · 0 likes Chromatography questions need the method before anything else: column, gradient, wavelength, injection volume. A purity figure with no method attached cannot be…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #7 · Access › Pricing · 22 Feb 2026 · 23 likes This follows post #5 rather than contradicting it. Where somebody posts a comparison, the useful version states the date, the region and what was included.
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #46 · Research Methods › N-of-1 designs · 15 Feb 2026 · 32 likes Taking post #45 at face value and following it one step further. Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias.…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #88 · Access › Pricing · 13 Feb 2026 · 0 likes This follows post #87 rather than contradicting it. I have been on both sides of the Price changes argument in this category within eighteen months, which should tell…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #22 · Outcomes › Progress reports · 9 Feb 2026 · 29 likes Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool; use the same one each time. Consistency matters more than…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #35 · Sourcing › Logistics · 8 Feb 2026 · 0 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance. Old habit: I write down the expected answer before I…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #22 · Research Methods › N-of-1 designs · 18 Jan 2026 · 0 likes Worth separating two things that post #20 runs together. Adding a small correction to the Pre-registering a personal experiment summary above rather than a disagreement…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #44 · Devices › Pens & autoinjectors · 15 Jan 2026 · 0 likes Worth separating two things that post #40 runs together. A pen that will not dial to the intended dose is usually telling you the cartridge does not contain enough for…
-
Waist circumference technique and its repeatability Replied, post #37 · Outcomes › Progress reports · 11 Jan 2026 · 2 likes No notes. Posting so the count is not one.
-
What to include when your question involves a chromatogram Replied, post #30 · Start Here › How to Ask · 9 Jan 2026 · 4 likes Nobody minds being asked to explain a term. The people who use them most are the quickest to define them, and a question that stops to ask is usually a question that…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #83 · Practice › Interactions · 5 Jan 2026 · 7 likes The question underneath Warfarin and altered intake is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down…
-
Guidelines revision: what changed and why — one year on Replied, post #54 · Meta › Announcements · 4 Jan 2026 · 4 likes Picking up post #51: that is the part I would want checked first. I have been on both sides of the Guidelines revision argument in this category within eighteen months,…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #29 · Sourcing › Red flags · 28 Dec 2025 · 0 likes Where I part company with post #27, and it is a narrow parting. Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact repeatedly…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #8 · Practice › Reconstitution · 13 Dec 2025 · 17 likes Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one — one… Replied, post #8 · Compounds › Oral incretins · 12 Dec 2025 · 1 like The class is broadening fast enough that anything written here about which orals exist is dated within a year. The mechanisms and the formulation constraints age much…
-
Absence of evidence and evidence of absence Replied, post #8 · Research Methods › Statistics · 7 Dec 2025 · 32 likes Absence of evidence and evidence of absence: if a study is small and finds no effect, that is absence of evidence, not evidence of absence. A larger study might find an…
-
Pen dose counters: what a click does and does not guarantee Replied, post #31 · Devices › Pens & autoinjectors · 14 Nov 2025 · 6 likes Storage instructions for a pen typically differ before and after first use, and the in-use period is the one people miss. It is on the carton. Written in the hope of…
-
Thyroid function tests during substantial weight change Replied, post #116 · Clinical › Bloodwork · 31 Oct 2025 · 0 likes Before the thread moves on from thyroid function tests during substantial — what is the sample size behind the claim? I am not being difficult; I have seen the same…
-
A 40-week log with the measurement method stated Replied, post #4 · Outcomes › Progress reports · 12 Oct 2025 · 0 likes The opening post put the caveat in the right place and I want to underline it. A single scale used throughout beats a more accurate scale introduced halfway through.…
-
Coverage in the US: a map of the usual obstacles Started this topic · Regional › North America · 9 Oct 2025 · 17 likes Coverage in the US: a map of the usual obstacles — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary conditions on…
-
[2026 update] A single out-of-range value on an otherwise normal panel Replied, post #14 · Clinical › Bloodwork · 6 Oct 2025 · 0 likes Add biological variation and analytical imprecision to that base rate and the probability of a meaningless flag on a multi-analyte panel is substantial.
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #43 · Analytics › COA interpretation · 28 Sep 2025 · 1 like The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #46 · Practice › Storage & stability · 20 Sep 2025 · 31 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear.
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #16 · Start Here › How to Ask · 19 Sep 2025 · 22 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. One of those cases where knowing the…
-
What a regulator's shortage notice actually authorises — what changed since Replied, post #7 · Sourcing › Regulatory · 13 Sep 2025 · 3 likes Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported.
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #32 · Analytics › COA interpretation · 8 Sep 2025 · 1 like Residual solvent screening is not standard on these documents and its presence is a signal about the manufacturer's own systems rather than about the vial. The general…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #46 · Data & Tools › Datasets · 8 Sep 2025 · 7 likes Small methodological point on Aggregated purity results across four: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #11 · Data & Tools › Datasets · 6 Sep 2025 · 0 likes Thank you for the correction. I would rather find out here than later.
-
Request: show the solution author in the topic list Replied, post #2 · Meta › Feature requests · 1 Sep 2025 · 7 likes Modest request: remember my sort preference per category rather than globally. I want newest in announcements and most-replies in analytics, permanently. The number is…
-
An emergency department visit, described afterwards Replied, post #61 · Safety › Adverse events · 1 Sep 2025 · 31 likes The most useful contribution to this subcategory is a completed account: what happened, what was done, and what the outcome was. The confident version of this sentence…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #19 · Practice › Side effects · 27 Aug 2025 · 21 likes Agreed on nausea timeline, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not,…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #43 · Practice › Reconstitution · 17 Aug 2025 · 12 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #67 · Compounds › Secretagogues & GH axis · 15 Aug 2025 · 0 likes Post #65 describes the usual case. This is about the unusual one. Effects reported at the level of appetite are the most consistently described and the most…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #27 · Compounds › Oral incretins · 13 Aug 2025 · 0 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #25 · Pharmacology › Receptor biology · 9 Aug 2025 · 27 likes Long-term receptor changes: very little is known about what happens to receptor expression, signalling, and downstream effects over years of exposure to these…
-
A calculator that gives a right answer to the wrong question — does this still hold? Replied, post #4 · Data & Tools › Calculators · 6 Aug 2025 · 3 likes Building on the opening post rather than restating it. Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #16 · Compounds › Secretagogues & GH axis · 27 Jul 2025 · 16 likes Storage: these are lyophilised short peptides and are generally reasonably stable dry and considerably less so in solution. Reconstituting only what will be used within…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #42 · Practice › Dosing & titration · 17 Jul 2025 · 25 likes On post #40 — agreed on the reasoning, with one qualification. Small methodological point on Escalating every six weeks instead: repeating a measurement is cheap and…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #2 · marked as the solution · Compounds › Semaglutide · 17 Jul 2025 · 14 likes Gallbladder events appear in the labelling for this class and are more common with larger, faster weight reduction. The mechanism is not specific to the drug — rapid…
-
Coming back to: Why semaglutide solutions can look faintly opalescent and when that… Replied, post #17 · Compounds › Semaglutide · 4 Jul 2025 · 7 likes No disagreement from me. Posting only so the question does not look ignored.
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #20 · Compounds › Secretagogues & GH axis · 30 Jun 2025 · 1 like Injection-site reactions are reported more often in this family than for the incretins. Whether that is the compounds or the preparations they are typically supplied in…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #75 · Practice › Storage & stability · 29 Jun 2025 · 19 likes A supplier stability statement tied to a named storage condition can be evaluated. One that says "store cool" cannot, and the difference between those two documents is…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #14 · Practice › Reconstitution · 20 Jun 2025 · 23 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #92 · Access › Insurance & coverage · 13 Jun 2025 · 0 likes The denial letter is the specification for your appeal. It states a criterion, and the job is to demonstrate that the criterion is met in the letter's own language.
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #85 · Access › Insurance & coverage · 12 Jun 2025 · 17 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #10 · Analytics › Method validation · 6 Jun 2025 · 4 likes Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance. Almost nothing discussed here has one. I am aware this is the…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #9 · Compounds › Cagrilintide & amylin analogues · 3 Jun 2025 · 8 likes Everything in post #5 holds. The case it does not cover is the one I have. Cagrilintide alone is discussed less than in combination because the published data is almost…
-
Publishing an inconvenient result: a case study Replied, post #27 · Sourcing › Independent verification · 31 May 2025 · 0 likes Worth stating the null on publishing an inconvenient result before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does…
-
IGF-1 as a surrogate endpoint and its limitations — the long version Replied, post #5 · Compounds › Secretagogues & GH axis · 27 May 2025 · 0 likes Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single post-dose growth hormone level is nearly uninterpretable. Assessing…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #68 · Compounds › Secretagogues & GH axis · 23 May 2025 · 0 likes I had written a reply contradicting post #64 and deleted it. Here is what survived. Storage: these are lyophilised short peptides and are generally reasonably stable…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #69 · Outcomes › Body composition · 20 May 2025 · 6 likes Preserving lean tissue during a substantial deficit depends on protein intake and a resistance stimulus, and the evidence for both is reasonably strong. Two sources,…
-
Pregnancy as an absolute contraindication Replied, post #81 · Safety › Contraindications · 20 May 2025 · 0 likes On post #77 — agreed on the reasoning, with one qualification. Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying. Pre-existing…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #40 · Clinical › Comorbidities · 14 May 2025 · 1 like Agreed, and I will stop repeating the version of this I had been repeating.
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #8 · Clinical › Special populations · 13 May 2025 · 0 likes Extrapolating a point estimate to somebody well outside the enrolled range should be described as an extrapolation every time it is done.
-
Follow-up: What other technical communities get right that we do not Replied, post #95 · Lounge › Off topic · 12 May 2025 · 17 likes Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has affected your life, the Lounge is the place for that.
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #14 · Compounds › Cagrilintide & amylin analogues · 10 May 2025 · 0 likes Injection-site tolerability is reported more often for this compound than for the incretins, and it is worth reading the trial reports rather than the summaries on that…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #27 · Clinical › Comorbidities · 3 May 2025 · 28 likes Marking my place. If it changes for me I will come back and say so.
-
Validating a calculator against hand arithmetic — what changed since Replied, post #35 · Data & Tools › Calculators · 26 Apr 2025 · 22 likes Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are fixed when identified. One case, stated as one case.
-
Reverting an edit that had no revision note Started this topic · Meta › Wiki maintenance · 20 Apr 2025 · 0 likes Posting this under the heading it deserves: Reverting an edit that had no revision note Everything below is what sits behind that. Reverting an edit: setting out the…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #51 · Practice › Reconstitution · 16 Apr 2025 · 15 likes Understood. Thank you for being specific about the limits of it.
-
Publishing an inconvenient result: a case study Replied, post #8 · Sourcing › Independent verification · 14 Apr 2025 · 2 likes On publishing an inconvenient result I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating…
-
[2026 update] Dose numbers across compounds are not on the same scale Replied, post #10 · Practice › Dosing & titration · 12 Apr 2025 · 1 like Noted, and I have changed what I was going to do on the strength of it.
-
Validating a calculator against hand arithmetic — what changed since Replied, post #9 · Data & Tools › Calculators · 9 Apr 2025 · 0 likes Where I have landed on Validating a calculator against hand, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a…
-
Scheduled maintenance and what will be unavailable Replied, post #97 · Meta › Announcements · 4 Apr 2025 · 24 likes The arithmetic in post #94 is right; the assumption feeding it is the part to check. I disagree with the framing of scheduled maintenance above, and I think it is a…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #95 · Access › International · 12 Mar 2025 · 8 likes On post #93 — agreed on the reasoning, with one qualification. On Cross-border purchase within I would separate what is worth knowing from what is worth acting on. The…
-
Particulates in a reconstituted solution: identifying the likely source — what changed… Started this topic · Analytics › Impurities & related substances · 5 Mar 2025 · 0 likes Particulates in a reconstituted solution: identifying the likely source — what changed since — setting out what I have, and where I think it stops being reliable. What…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #15 · Practice › Reconstitution · 11 Feb 2025 · 21 likes Worth separating two things that post #13 runs together. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #88 · Evidence › Meta-analyses · 10 Feb 2025 · 14 likes No notes. Posting so the count is not one.
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #82 · Data & Tools › Calculators · 8 Feb 2025 · 0 likes Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…
-
Protein density versus volume when you cannot eat much Replied, post #31 · Nutrition & Training › Protein & intake · 28 Jan 2025 · 0 likes Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than trying to hit the whole target at one sitting on suppressed…
-
Fixed versus detachable needles: the trade-offs Replied, post #119 · Devices › Syringes & needles · 17 Jan 2025 · 23 likes Helpful, and short, which on this subject is harder than long.
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #17 · Compounds › Oral incretins · 3 Jan 2025 · 12 likes This follows post #14 rather than contradicting it. SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH…
-
Isotonicity and what happens when you get it wrong Replied, post #12 · Pharmacology › Formulation chemistry · 30 Dec 2024 · 3 likes Taking post #11 at face value and following it one step further. The bit of isotonicity that nobody enjoys is that the answer changes depending on what you are trying…
-
Criticising the method without criticising the authors Replied, post #27 · Evidence › Study critique · 27 Dec 2024 · 23 likes I had written a reply contradicting post #25 and deleted it. Here is what survived. Defending a paper against criticism: if the authors respond, they might clarify…
-
What we do not know about retatrutide, listed explicitly Replied, post #34 · Compounds › Retatrutide · 27 Dec 2024 · 13 likes Everything in post #32 holds. The case it does not cover is the one I have. Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote —…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #11 · Analytics › Mass spectrometry · 25 Dec 2024 · 30 likes Picking up post #10: that is the part I would want checked first. The thing about mass spectrometry that took me longest to accept is that a plausible mechanism is not…
-
Body image changing more slowly than the body Replied, post #126 · Wellbeing › Mental health · 25 Dec 2024 · 0 likes If you are in crisis, contact a local emergency or crisis service rather than posting. A volunteer forum cannot help and waiting costs time. Not disagreeing with anyone…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #5 · Compounds › Other compounds · 16 Dec 2024 · 16 likes I read the opening post twice before replying, because I had assumed the opposite. A compound with no established assay is a compound where a certificate can say almost…
-
Feature request: should a dose-equivalence tool exist at all? Started this topic · Data & Tools › Calculators · 15 Dec 2024 · 43 likes Feature request: should a dose-equivalence tool exist at all? — that is the question, and I have not found it answered plainly anywhere I have looked. Reading back…
-
Revisiting: Moderation log format change Replied, post #64 · Meta › Announcements · 11 Dec 2024 · 23 likes Taking post #61 at face value and following it one step further. The moderation log will carry the announcement entry, so the date is recoverable. It will not be…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #131 · Analytics › COA interpretation · 27 Nov 2024 · 2 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #43 · Clinical › Prescriber conversations · 8 Nov 2024 · 0 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Time to steady state after a dose increase Replied, post #144 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 2 likes Area under the curve is the exposure measure that matters for most effects in this class. Peak concentration matters more for tolerability.
-
A promotion I argued against, and why I lost Started this topic · Documentation › Doc review · 5 Nov 2024 · 5 likes Posting this under the heading it deserves: A promotion I argued against, and why I lost Everything below is what sits behind that. Two things I would like separated…
-
Time to steady state after a dose increase Replied, post #70 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 5 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #104 · Analytics › COA interpretation · 2 Nov 2024 · 27 likes Two claims get bundled together under field-by-field walk through a certificate and they need separating. The descriptive one — this is what was observed — is usually…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #7 · Clinical › Comorbidities · 8 Oct 2024 · 0 likes I would put moderate confidence on the mainstream reading of Hypertension improvement and no more. That is not scepticism for its own sake; it is where the sourcing…
-
How to ask for a dose change without antagonising anyone Replied, post #24 · Clinical › Prescriber conversations · 10 Sep 2024 · 14 likes Taking post #23 at face value and following it one step further. Asking what would change the plan is more productive than asking whether the plan is right. It gets you…
-
Circumference measurements as a poor man's composition estimate Replied, post #111 · Outcomes › Body composition · 30 Aug 2024 · 0 likes DXA (dual-energy X-ray absorptiometry): the standard for body composition in research. Precision is roughly ±1 kg for lean mass. Two scans six months apart on the same…
-
Promotion criteria, and the one that stops most nominations Replied, post #47 · Documentation › Doc review · 27 Aug 2024 · 7 likes Where I part company with post #45, and it is a narrow parting. Promotion criteria: I would want to see the raw numbers rather than the summary before agreeing.…
-
[2026 update] People with a low starting BMI: where the evidence stops Replied, post #2 · Clinical › Special populations · 25 Aug 2024 · 20 likes Extrapolating a point estimate to somebody well outside the enrolled range should be described as an extrapolation every time it is done.
-
Correlation in a self-tracked dataset: what it can support Replied, post #30 · Research Methods › Statistics · 21 Aug 2024 · 2 likes Number needed to treat: how many people need to be treated to prevent one bad outcome or achieve one good outcome. More intuitive than relative risk reduction. Reading…
-
Cold packs, phase-change material, and what survives ten days Replied, post #113 · Sourcing › Logistics · 17 Jul 2024 · 0 likes Worth separating two things that post #112 runs together. Cold packs came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself…
-
Pen wastage and its effect on real cost Replied, post #2 · Access › Pricing · 16 Jun 2024 · 31 likes The opening post is right about the mechanism and I think understates the practical bit. Independent testing is a real cost and belongs in the comparison. A cheaper…
-
Why I ask for the gradient before I discuss the number Started this topic · Analytics › HPLC & UHPLC · 4 Jun 2024 · 12 likes The question in the title: Why I ask for the gradient before I discuss the number I will give what I have already checked below so nobody repeats it. I would like to…
-
Assessing a warm arrival: the decision process — one year on Replied, post #131 · Sourcing › Logistics · 2 Jun 2024 · 0 likes The version of Assessing a warm arrival that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
Assessing a warm arrival: the decision process — one year on Replied, post #104 · Sourcing › Logistics · 1 Jun 2024 · 9 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…